TR200002803T2 - MRP1 inhibe etmek için yöntemler. - Google Patents

MRP1 inhibe etmek için yöntemler.

Info

Publication number
TR200002803T2
TR200002803T2 TR2000/02803T TR200002803T TR200002803T2 TR 200002803 T2 TR200002803 T2 TR 200002803T2 TR 2000/02803 T TR2000/02803 T TR 2000/02803T TR 200002803 T TR200002803 T TR 200002803T TR 200002803 T2 TR200002803 T2 TR 200002803T2
Authority
TR
Turkey
Prior art keywords
methods
mrp1
inhibit
inhibit mrp1
useful
Prior art date
Application number
TR2000/02803T
Other languages
English (en)
Inventor
Michael Gruber Joseph
Hurst Norman Bryan
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200002803T2 publication Critical patent/TR200002803T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Mevcut bulus, direncin kismen veya bütünüyle MRP1'den kaynaklandigi dirençli neoplazmalarin inhibe edilmesi için yararli olan bir formül (I) bilesigi ile ilgilidir.
TR2000/02803T 1998-04-08 1999-04-07 MRP1 inhibe etmek için yöntemler. TR200002803T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8107798P 1998-04-08 1998-04-08

Publications (1)

Publication Number Publication Date
TR200002803T2 true TR200002803T2 (tr) 2000-12-21

Family

ID=22161958

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02803T TR200002803T2 (tr) 1998-04-08 1999-04-07 MRP1 inhibe etmek için yöntemler.

Country Status (17)

Country Link
US (1) US6417193B1 (tr)
EP (1) EP1069897A1 (tr)
JP (1) JP2002510624A (tr)
KR (1) KR20010042482A (tr)
CN (1) CN1296408A (tr)
AU (1) AU3468099A (tr)
BR (1) BR9909497A (tr)
CA (1) CA2327706A1 (tr)
EA (1) EA200001036A1 (tr)
HU (1) HUP0101736A3 (tr)
ID (1) ID27048A (tr)
IL (1) IL138391A0 (tr)
NO (1) NO20005042D0 (tr)
PL (1) PL343312A1 (tr)
SK (1) SK15002000A3 (tr)
TR (1) TR200002803T2 (tr)
WO (1) WO1999051227A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743794B2 (en) 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
PT1250340E (pt) * 1999-12-22 2005-04-29 Lilly Co Eli Metodos e compostos para inibicao de mrp1
WO2001096346A1 (en) * 2000-06-14 2001-12-20 Eli Lilly And Company Tricyclic compounds as mrp1-inhibitors
WO2002000624A2 (en) * 2000-06-23 2002-01-03 Eli Lilly And Company Methods and compounds for inhibiting mrp1
JP2004509897A (ja) * 2000-09-22 2004-04-02 イーライ・リリー・アンド・カンパニー シクロヘキシルアミン誘導体の立体選択的製造方法
US7037921B2 (en) 2001-04-09 2006-05-02 Eli Lilly And Company Compounds and methods for inhibiting MRP1
CN1281210C (zh) * 2003-11-29 2006-10-25 胡汛 五味子乙素在制备治疗肿瘤药物中的应用
CN104002843A (zh) * 2014-05-29 2014-08-27 安徽银龙泵阀股份有限公司 一种减震效果好易于放置的双泵移动车

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5717092A (en) 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity

Also Published As

Publication number Publication date
NO20005042L (no) 2000-10-06
EP1069897A1 (en) 2001-01-24
NO20005042D0 (no) 2000-10-06
CA2327706A1 (en) 1999-10-14
US6417193B1 (en) 2002-07-09
ID27048A (id) 2001-02-22
KR20010042482A (ko) 2001-05-25
BR9909497A (pt) 2000-12-12
JP2002510624A (ja) 2002-04-09
IL138391A0 (en) 2001-10-31
SK15002000A3 (sk) 2001-06-11
WO1999051227A1 (en) 1999-10-14
PL343312A1 (en) 2001-08-13
HUP0101736A2 (hu) 2001-11-28
EA200001036A1 (ru) 2001-04-23
HUP0101736A3 (en) 2002-04-29
AU3468099A (en) 1999-10-25
CN1296408A (zh) 2001-05-23

Similar Documents

Publication Publication Date Title
ATE316531T1 (de) Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1
TR200000065T2 (tr) Epotilon türevleri.
ATE315567T1 (de) A-1-adenosin rezeptor antagoniste
TR200101893T2 (tr) Antiviral maddeler olarak 4-okso-1,4 dihidro -3- kuinolinkarboksamitler.
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
TR200002851T2 (tr) MRP1'i inhibe etmek için yöntemler.
TR200002803T2 (tr) MRP1 inhibe etmek için yöntemler.
TW427979B (en) A condensed piperidine compound
EA200200729A1 (ru) Производные 4-фенил-1-пиперазинила, -пиперидинила и -тетрагидропиридила
TR200002804T2 (tr) MRP1 inhibe etmek için yöntemler
EA200200727A1 (ru) Новые производные индола
SE0101651D0 (sv) Synthesis and evaluation of new cyanine dyes as minor groove binders
ATE278697T1 (de) Katalysatoren
TR200402754T4 (tr) Yeni benzosultam oksazolidinon antibakteriyel maddeler.
TR199700481A2 (tr) Sefem ve izooksafem türevlerinin hazirlanmasi.
ATE367377T1 (de) Bis(5-aryl-2-pyridyl)derivate
TR200003360T2 (tr) Farmasotik norbenzomorfan türevleri imalatı için iyileştirilmiş yöntem
MY117662A (en) Organic compounds
ES2143974T3 (es) Analogos de prostaglandina i.
ECSP982576A (es) Derivados de epotilona
DE60207709D1 (de) Verbindungen und methoden zur inhibierung von mrp1
ATE299883T1 (de) Verbindungen und methoden zur hemmung von mrp1
TH42384A (th) อนุพันธ์ d-โปรไลน์